Avicanna Inc. (AVCNF)
OTCMKTS · Delayed Price · Currency is USD
0.2008
+0.0092 (4.80%)
Jul 31, 2025, 11:50 AM EDT
Avicanna Market Cap
Avicanna has a market cap or net worth of $23.90 million as of August 1, 2025. Its market cap has decreased by -31.97% in one year.
Market Cap
23.90M
Enterprise Value
29.28M
Revenue
17.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.20
Market Cap Chart
Since July 18, 2019, Avicanna's market cap has decreased from 104.82M to 23.90M, a decrease of -77.20%. That is a compound annual growth rate of -21.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 23.90M | 2.32% |
| Dec 31, 2024 | 23.36M | -2.78% |
| Dec 29, 2023 | 24.03M | 5.84% |
| Dec 30, 2022 | 22.71M | -19.71% |
| Dec 31, 2021 | 28.28M | -26.61% |
| Dec 31, 2020 | 38.54M | -11.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 563.22M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.98M |
| Northwest Biotherapeutics | 351.67M |